A collection of 21 posts
While the British Medical Association now acknowledges that the Cass Review has been ‘vindicated,’ its Canadian counterparts still remain beholden to debunked activist slogans.
A new gene therapy that relies on gain-of-function research promises a breakthrough in neurodegenerative medicine and provides new hope for sufferers from a horrific disease.
Healthcare for menopause and perimenopause is the single most patient-betraying area of medicine—but it has plenty of company.
Musk and Trump are inflicting catastrophic damage on biomedical research.
Vaccination against UTIs is a novel idea that holds enormous promise, but clinical trials must be well-designed and carefully analysed.
A 2020 study found that black newborns attended by white doctors die at twice the rate of those in the care of black doctors. The study’s refutation last year has not altered the progressive narrative of systemic racism in medicine.
A prominent South Carolina doctor and transgender rights activist has made a great show of calling England’s Cass Review “a sham at best”—but now refuses to say why.
A landmark report properly emphasises the application of science, not slogans, in establishing treatment protocols for trans-identified children.
The success of the academy requires academic freedom and tolerance for viewpoint diversity. These critical values are under increasing threat.
Autism has become a catchall term to explain and dismiss the problem child. But it can also be viewed as a superpower.
Gender clinics from Stockholm to San Francisco have been running an uncontrolled experiment on children, while cloaked in the mantle of human rights.
The Nocebo Effect occurs when we experience pain, depression, or illness based on nothing more than negative expectations.
New pharmaceuticals appear to offer a genuine solution to the problem of excess appetite, that uncontrollable urge to eat more than we need to that keeps so many of us fat.
Evidence that clinical decisions are driven by unconscious bias remains conspicuously lacking.
Canada’s Medical Assistance in Dying program, once reserved for the terminally ill, is increasingly attracting applicants experiencing poverty and depression.